heptakis(2,6-o-dimethyl)beta-cyclodextrin and Hemolysis

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with Hemolysis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bácskay, I; Fenyvesi, E; Fenyvesi, F; Iványi, R; Kiss, T; Szente, L; Tósaki, A; Váradi, J; Vecsernyés, M	1

Other Studies

1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and Hemolysis

Article	Year
Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Jul-11, Volume: 40, Issue:4 Topics: beta-Cyclodextrins; Caco-2 Cells; Cell Survival; Cholesterol; Erythrocytes; Excipients; Hemolysis; Hemolytic Agents; Humans; Inhibitory Concentration 50; Methylation; Solubility; Structure-Activity Relationship	2010

Article

Year

Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2010, Jul-11, Volume: 40, Issue:4

Topics: beta-Cyclodextrins; Caco-2 Cells; Cell Survival; Cholesterol; Erythrocytes; Excipients; Hemolysis; Hemolytic Agents; Humans; Inhibitory Concentration 50; Methylation; Solubility; Structure-Activity Relationship

2010